Prostatectomy News and Research RSS Feed - Prostatectomy News and Research

CMS publishes draft coverage decision for Decipher Prostate Cancer Classifier

CMS publishes draft coverage decision for Decipher Prostate Cancer Classifier

GenomeDx Biosciences today announced that a draft local coverage determination (LCD) for its Decipher® Prostate Cancer Classifier has been published by the Centers for Medicare and Medicaid Services (CMS) describing a coverage and payment policy for use of the Decipher test in men who have undergone radical prostatectomy. [More]
Conventional laparoscopy less complicated than robot-assisted surgery for benign gynecologic conditions

Conventional laparoscopy less complicated than robot-assisted surgery for benign gynecologic conditions

For benign gynecologic conditions, robot-assisted surgery involves more complications during surgery and may be significantly more expensive than conventional laparoscopic surgery, according to a study by researchers at Columbia University Medical Center. [More]
Metamark expands prostate cancer test services to include PROGENSAPCA3 assay

Metamark expands prostate cancer test services to include PROGENSAPCA3 assay

Metamark announced today the expansion of its prostate cancer test services to now include the PROGENSA® PCA3 assay, a urine-based test that can help confirm negative prostate biopsies, and ERG, a companion test to the company's existing PTEN assay. [More]
Experts share tips on prevention of prostate cancer

Experts share tips on prevention of prostate cancer

Prostate cancer is the second leading cause of cancer death in American men. One in seven men will be diagnosed with prostate cancer and 233,000 new cases are diagnosed annually. [More]
Study: US experienced widespread adoption of robot-assisted prostate removal surgery in recent years

Study: US experienced widespread adoption of robot-assisted prostate removal surgery in recent years

A new study reveals that the US has experienced widespread adoption of robot-assisted prostate removal surgery to treat prostate cancer in recent years. The BJU International study also found that while such surgeries are more expensive than traditional surgeries, their costs are decreasing over time. [More]
Study reveals treatment trends for prostate cancer in Japan

Study reveals treatment trends for prostate cancer in Japan

There has been a recent increase in use of radiotherapy in Japanese men newly diagnosed with prostate cancer and a concomitant decrease in use of androgen deprivation therapy, study findings indicate. [More]
Pelvic anatomy changes after prostatectomy linked to LUTS

Pelvic anatomy changes after prostatectomy linked to LUTS

Japanese researchers have identified certain pelvic anatomic features in men who have undergone radical prostatectomy that are associated with specific lower urinary tract symptoms. [More]
Robot-assisted surgery to control prostate cancer effective in controlling disease for 10 years

Robot-assisted surgery to control prostate cancer effective in controlling disease for 10 years

Robot-assisted surgery to remove cancerous prostate glands is effective in controlling the disease for 10 years, according to a new study led by researchers at Henry Ford Hospital. [More]
NAFC updates Male Stress Urinary Incontinence content

NAFC updates Male Stress Urinary Incontinence content

The National Association For Continence (NAFC) has updated the Male Stress Urinary Incontinence content at www.nafc.org. The new content is designed to be more patient friendly and includes an educational video, as well as additional resources about the diagnosis, treatment, and management of Male Stress Urinary Incontinence. [More]
Study explores how surgical innovation can lead to adverse events for patients

Study explores how surgical innovation can lead to adverse events for patients

Researchers at the University of California, San Diego School of Medicine have found that the risk of patient harm increased two-fold in 2006 - the peak year that teaching hospitals nationwide embraced the pursuit of minimally invasive robotic surgery for prostate cancer. Results of the study are published in the July 2 online issue of JAMA Surgery. [More]
Study: Most physicians don't recommend active surveillance for low-risk prostate cancer

Study: Most physicians don't recommend active surveillance for low-risk prostate cancer

Specialists who treat prostate cancer agree that active surveillance is an effective option-yet most don't recommend it when appropriate for their own patients, according to a study in the July issue of Medical Care. The journal is published by Lippincott Williams & Wilkins , a part of Wolters Kluwer Health. [More]
ProMark test for prostate cancer meets primary endpoint

ProMark test for prostate cancer meets primary endpoint

Today, for the first time, Metamark presents results from the clinical validation study that showed ProMark, the first and only proteomic-based imaging biopsy test, achieved its primary endpoint by accurately differentiating between aggressive and non-aggressive forms of prostate cancer at early stages of disease. [More]
Robot-assisted surgery for removing cancerous prostate glands as safe as open surgery, but expensive

Robot-assisted surgery for removing cancerous prostate glands as safe as open surgery, but expensive

Minimally invasive robot-assisted surgery, which has become the main choice for surgically removing cancerous prostate glands during recent years, is as safe as open surgery for Medicare patients over age 65. [More]
Findings suggest usage of statins after surgery may reduce risk of prostate cancer recurrence

Findings suggest usage of statins after surgery may reduce risk of prostate cancer recurrence

Men who begin taking statins after prostate cancer surgery are less likely to have a recurrence of their cancer, according to a retrospective analysis led by researchers at Duke Medicine. [More]
Noninvasive technique detects prostate cancer using an electronic nose

Noninvasive technique detects prostate cancer using an electronic nose

We may soon be able to make easy and early diagnoses of prostate cancer by smell. Investigators in Finland have established that a novel noninvasive technique can detect prostate cancer using an electronic nose. In a proof of principle study, the eNose successfully discriminated between prostate cancer and benign prostatic hyperplasia (BPH) by "sniffing" urine headspace (the space directly above the urine sample). Results using the eNose are comparable to testing prostate specific antigen (PSA), reports the Journal of Urology. [More]
Research roundup: Structural concerns in ACOs; public's view of mandated contraception coverage

Research roundup: Structural concerns in ACOs; public's view of mandated contraception coverage

The Medicare Accountable Care Organization (ACO) programs reward participating health care provider groups that achieve slower spending growth and high quality of care. [More]

Intravesical prostatic protrusion predicts post-surgery incontinence

The length of intravesical prostatic protrusion in men undergoing radical prostatectomy predicts the likelihood that they will develop incontinence following surgery, Korean researchers have shown. [More]
Adjuvant radiotherapy after prostatectomy ‘risks urinary incontinence’

Adjuvant radiotherapy after prostatectomy ‘risks urinary incontinence’

Men who receive adjuvant radiation therapy following radical prostatectomy face a significantly increased risk of urinary incontinence in the following years, study findings indicate. [More]

Prostate stiffness is a risk factor for voiding dysfunction

Prostate elasticity is an independent risk factor for urinary voiding symptoms, although not for lower urinary tract symptoms in general or storage symptoms, clinical research indicates. [More]

Study finds long-term reduction in mortality for young men who undergo radical prostatectomy

More than 230,000 men will be diagnosed with prostate cancer this year in the United States, but determining their course of treatment remains a source of considerable debate. A new study by researchers from Uppsala University Hospital, Sweden, Harvard School of Public Health and colleagues—which draws from one of the few randomized trials conducted to directly address this issue—finds a substantial long-term reduction in mortality for men with localized cancer who undergo a radical prostatectomy. [More]